Skip to content
OpenCapital
Get started

Eton Pharmaceuticals, Inc. ETON Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$18.9MMiss by $1.5MDiluted EPS-$0.10Miss by $0.09
Revenue estimate$20.5M
EPS estimate-$0.01

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$26.9M
EPS estimate$0.13

Financials

Q2 2025

Income statement

See full
Revenue$18.9M+109%
Gross profit$11.9M+112%
Operating income-$1.5M+49.7%
Net income-$2.6M+15.0%

Balance sheet

See full
Cash & equivalents$25.4M+43.4%
Total debt$30.7M+529%
Total equity$24.0M+78.0%
Total assets$101.7M+220%

Cash flow

See full
Operating cash flow$8.0M—
CapEx-—
Free cash flow$8.0M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$364.45M+331%
Enterprise value$369.77M+416%
P/S6.3×+3.6×

Profitability

See full
Gross margin59.4%-0.1pp
Net margin-7.1%-2.8pp

Returns & leverage

See full
Return on equity-22.1%-7.4pp
Debt / equity1.3×+0.9×
Current ratio1.8×+0.4×

Versus estimates

Revenue

Q1 2026$24.3MBeat by $2.0MQ4 2025$21.3MBeat by $1.3MQ3 2025$22.5MBeat by $2.0M
Q2 2025$18.9MMiss by $1.5M
Q1 2025$17.3MBeat by $2.2MQ4 2024$11.6MMiss by $2.7M

Diluted EPS

Q1 2026$0.05Miss by $0.05Q4 2025$0.05Miss by $0.07Q3 2025-$0.07Miss by $0.23
Q2 2025-$0.10Miss by $0.09
Q1 2025$0.07Miss by $0.02Q4 2024-$0.02In line

Ask the moment Eton Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Eton Pharmaceuticals, Inc. report Q2 2025 earnings?
Eton Pharmaceuticals, Inc. (ETON) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Eton Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
Eton Pharmaceuticals, Inc. reported revenue of $18.9M and diluted EPS of $-0.10 for Q2 2025.
Did Eton Pharmaceuticals, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $20.5M by $1.5M. EPS missed the consensus estimate of $-0.01 by $0.09.
How did Eton Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 108.6% from $9.1M a year earlier and diluted EPS grew 16.7% from $-0.12.
Where can I find Eton Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001437749-25-025444) directly on SEC EDGAR. The filing index links above go to sec.gov.